Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
5.15
-0.77 (-13.01%)
At close: May 12, 2025, 4:00 PM
5.48
+0.33 (6.41%)
After-hours: May 12, 2025, 7:46 PM EDT
Alzamend Neuro Market Cap
Alzamend Neuro has a market cap or net worth of $3.78 million as of May 12, 2025. Its market cap has decreased by -22.48% in one year.
Market Cap
3.78M
Enterprise Value
417.10K
1-Year Change
-22.48%
Ranking
Category
Stock Price
$5.15
Market Cap Chart
Since the IPO on June 15, 2021, Alzamend Neuro's market cap has decreased from $1.15B to $3.78M, a decrease of -99.67%. That is a compound annual growth rate of -76.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 4.34M | -31.10% |
| Dec 31, 2024 | 6.30M | -0.56% |
| Dec 29, 2023 | 6.34M | -88.37% |
| Dec 30, 2022 | 54.47M | -67.73% |
| Dec 31, 2021 | 168.82M | -85.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |